|
||||||
Executive Summary Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, "Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 2016" provides an overview of Keratoconjunctivitis sicca (Dry Eye) clinical trials scenario. This report provides top line data relating to the clinical trials on Keratoconjunctivitis sicca (Dry Eye). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years Report provides latest news for the past three months *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Reasons to Buy Assists in formulating key business strategies with regards to investment Helps in identifying prominent locations for conducting clinical trials which saves time and cost Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities Supports understanding of trials count and enrollment trends by country in global therapeutics market Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials Facilitates clinical trial assessment of the indication on a global, regional and country level *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Read More Contact Us:
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Countries Contributing to Clinical Trials in Middle East and Africa 12 Top Countries Contributing to Clinical Trials in Central and South America 13 Clinical Trials by G7 Countries: Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials 14 Clinical Trials by Phase in G7 Countries 15 Clinical Trials in G7 Countries by Trial Status 16 Clinical Trials by E7 Countries: Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials 17 Clinical Trials by Phase in E7 Countries 18 Clinical Trials in E7 Countries by Trial Status 19 Clinical Trials by Phase 20 In Progress Trials by Phase 21 Clinical Trials by Trial Status 22 Clinical Trials by End Point Status 23 Subjects Recruited Over a Period of Time 24 Clinical Trials by Sponsor Type 25 Prominent Sponsors 26 Top Companies Participating in Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials 27 Prominent Drugs 29 Clinical Trial Profile Snapshots 30 Appendix 307 Abbreviations 307 Definitions 307 Research Methodology 308 Secondary Research 308 About GlobalData 309 Contact Us 309 Disclaimer 309 Source 310 List of Figures Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 13 Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 14 Keratoconjunctivitis sicca (Dry Eye) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Keratoconjunctivitis sicca (Dry Eye) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 17 Keratoconjunctivitis sicca (Dry Eye) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Keratoconjunctivitis sicca (Dry Eye) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20 Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21 Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29 GlobalData Methodology 308 List of Tables Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Region, 2016* 6 Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13 Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 14 Keratoconjunctivitis sicca (Dry Eye) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Keratoconjunctivitis sicca (Dry Eye) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 17 Keratoconjunctivitis sicca (Dry Eye) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Keratoconjunctivitis sicca (Dry Eye) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Phase, 2016* 20 Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21 Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29 Single User License: Site License: Corporate User License: Novartis AG, Allergan Plc, Santen Pharmaceutical Co Ltd, Valeant Pharmaceuticals International Inc, Otsuka Holdings Co Ltd, Innovative Medical Products Inc, Merck & Co Inc, Ora Inc, Pfizer Inc, Kissei Pharmaceutical Co Ltd Keratoconjunctivitis sicca (Dry Eye) Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Keratoconjunctivitis sicca (Dry Eye), Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania. |
select a license |
||
NEWSLETTER BY CATEGORY
|
||
Testimonials
|
||
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center" |